Abstract
BackgroundPreclinical studies showed that endothelin signalling is a major factor in perpetuating fibrotic responses in systemic sclerosis (SSc). Positive effects of endothelin-1 receptor antagonists (ETRA) have been demonstrated in pulmonary...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
